The detection of antibodies against Schistosoma mansoni soluble egg antigens (SEA) and CEF6 in ELISA, before and after chemotherapy

被引:18
作者
Doenhoff, MJ
Wheeler, JG
Tricker, K
Hamilton, JV
Sturrock, RF
Butterworth, AE
Ouma, JH
Mbugua, GG
Kariuki, C
Koech, D
机构
[1] Univ Wales Bangor, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales
[2] Univ Forvie Site, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England
[3] Manchester Royal Infirm, Dept Psychiat & Behav Sci, HERaM, Manchester M13 9WL, Lancs, England
[4] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England
[5] Biomed Res & Training Inst, Harare, Zimbabwe
[6] Kenya Minist Hlth, Div Vector Borne Dis, Nairobi, Kenya
[7] Kenya Govt Med Res Ctr, Nairobi, Kenya
来源
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY | 2003年 / 97卷 / 07期
关键词
D O I
10.1179/000349803225002354
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Circulating IgG antibodv reactivity and excreted egg counts were investigated in 489 Kenyans given chemotherapy for schistosomiasis mansoni. Antibody reactivity was measured in ELISA, using either unfractionated aqueous-soluble constituents of Schistosoma mansoni eggs (SEA) or CEF6 (a soluble fraction of S. mansoni eggs containing two cationic antigens) as the antigen source. Antibody reactivity for each antigen source was strongly associated with egg counts, both pre- and post-treatment. Approximately 6 months after chemotherapy, egg counts were zero in 84% of the subjects. The mean optical densities (OD) measured in the post-treatment ELISA were 60% (CEF6) or 45% (SEA) lower than the pre-treatment values, the reduction in the OD with CEF6 as antigen source being significantly greater than that observed with SEA (P < 0.001). The usefulness of an assay for antibody reactivity in monitoring the effects of the treatment of schistosomiasis is discussed.
引用
收藏
页码:697 / 709
页数:13
相关论文
共 31 条
[1]   COMPARISON OF DIFFERENT CHEMOTHERAPY STRATEGIES AGAINST SCHISTOSOMA-MANSONI IN MACHAKOS DISTRICT, KENYA - EFFECTS ON HUMAN INFECTION AND MORBIDITY [J].
BUTTERWORTH, AE ;
STURROCK, RF ;
OUMA, JH ;
MBUGUA, GG ;
FULFORD, AJC ;
KARIUKI, HC ;
KOECH, D .
PARASITOLOGY, 1991, 103 :339-355
[2]   LONGITUDINAL-STUDIES ON HUMAN SCHISTOSOMIASIS [J].
BUTTERWORTH, AE ;
FULFORD, AJC ;
DUNNE, DW ;
OUMA, JH ;
STURROCK, RF .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1988, 321 (1207) :495-511
[3]   IMMUNITY AFTER TREATMENT OF HUMAN SCHISTOSOMIASIS MANSONI .1. STUDY DESIGN, PRETREATMENT OBSERVATIONS AND THE RESULTS OF TREATMENT [J].
BUTTERWORTH, AE ;
DALTON, PR ;
DUNNE, DW ;
MUGAMBI, M ;
OUMA, JH ;
RICHARDSON, BA ;
SIONGOK, TKA ;
STURROCK, RF .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1984, 78 (01) :108-123
[4]   Assessment of cure by detection of circulating antigens in serum and urine, following schistosomiasis mass treatment in two villages of the Office du Niger, Mali [J].
De Clercq, D ;
Sacko, M ;
Vercruysse, J ;
vanden Bussche, V ;
Landouré, A ;
Diarra, A ;
Gryseels, B ;
Deelder, A .
ACTA TROPICA, 1997, 68 (03) :339-346
[5]   Circulating anodic and cathodic antigen in serum and urine of mixed Schistosoma haematobium and S-mansoni infections in Office du Niger, Mali [J].
DeClercq, D ;
Sacko, M ;
Vercruysse, J ;
vandenBussche, V ;
Landoure, A ;
Diarra, A ;
Gryseels, B ;
Deelder, A .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (07) :680-685
[6]   UNDERESTIMATION OF SCHISTOSOMA-MANSONI PREVALENCES [J].
DEVLAS, SJ ;
GRYSEELS, B .
PARASITOLOGY TODAY, 1992, 8 (08) :274-277
[7]  
DEVLAS SJ, 1993, PARASITOL TODAY, V9, P305
[8]   Praziquantel and the control of schistosomiasis [J].
Doenhoff, MJ ;
Kimani, G ;
Cioli, D .
PARASITOLOGY TODAY, 2000, 16 (09) :364-366
[9]   SEROEPIDEMIOLOGY AND SERODIAGNOSIS OF SCHISTOSOMIASIS IN KENYA USING CRUDE AND PURIFIED EGG ANTIGENS OF SCHISTOSOMA-MANSONI IN ELISA [J].
DOENHOFF, MJ ;
BUTTERWORTH, AE ;
HAYES, RJ ;
STURROCK, RF ;
OUMA, JH ;
KOECH, D ;
PRENTICE, M ;
BAIN, J .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1993, 87 (01) :42-48
[10]   Is schistosomicidal chemotherapy sub-curative? Implications for drug resistance [J].
Doenhoff, MJ .
PARASITOLOGY TODAY, 1998, 14 (10) :434-435